Loading stock data…
Kewaunee Scientific Corporation (KEQU)
$36.01-0.98 (-2.65%)
Market ClosedLast close Sep 8
Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Kewaunee Scientific Corporation in the Consumer Cyclical sector is trading at $36.01 with a market capitalization of $105M. The stock is currently near its 52-week low of $33.27, remaining 4.4% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $71.40M↑ | $69.40M↓ | $70.10M↓ | $71.10M↓ | $77.15M |
| Gross Profit | $21.25M↑ | $18.55M↓ | $19.72M↓ | $20.93M↓ | $24.04M |
| Operating Income | $5.22M↑ | $2.58M↓ | $4.11M↓ | $4.81M↓ | $8.50M |
| Net Income | $3.39M↑ | $692,000↓ | $2.44M↓ | $3.09M↓ | $4.85M |
Peer Comparison
AMZNTSLAHD
Fundamentals
Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segment...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$104.84M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.18
Beta
Defensive asset. Lower volatility than the S&P 500.
0.73
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.87%
Volume
Today's trading volume
1,554
Recent News
Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments
Kewaunee Scientific (NASDAQ:KEQU) reported record revenue and outlined continued investments in product development, manufacturing capacity, international expansion and potential acquisitions during its 2026 annual meeting of stockholders. President and Chief Executive Officer Thomas D. Hull III sa
The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific
Eli Lilly's expanding GLP-1 portfolio and pipeline remain in focus as demand stays strong ahead of its second-quarter earnings results.
Top Research Reports for Eli Lilly, Costco & Morgan Stanley
Eli Lilly's GLP-1 portfolio, pipeline progress and 2026 acquisitions are driving growth despite pricing pressure and rising competition.
Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing
KEQU posts lower Q4 sales and EPS as project timing and Middle East shipment delays weigh on the results despite annual revenue growth.
The Zacks Analyst Blog Highlights Caterpillar, Texas Instruments, Boeing, Kewaunee Scientific and Vaso
Caterpillar, Texas Instruments and Boeing stand out in Zacks research as strong demand, backlog and data center growth drive performance outlooks.